BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 11850817)

  • 1. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA; Merlino G
    Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor induces proliferation of lens epithelial cells through activation of ERK1/2 and JNK/SAPK.
    Choi J; Park SY; Joo CK
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2696-704. PubMed ID: 15277494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA; Merlino G
    Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade.
    Reboul P; Pelletier JP; Tardif G; Benderdour M; Ranger P; Bottaro DP; Martel-Pelletier J
    Arthritis Rheum; 2001 Jan; 44(1):73-84. PubMed ID: 11212179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
    Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription factor ATF-2 inhibits extracellular signal regulated kinase expression and proliferation of human cancer cells.
    Crowe DL; Shemirani B
    Anticancer Res; 2000; 20(5A):2945-9. PubMed ID: 11062705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
    Cacci E; Salani M; Anastasi S; Perroteau I; Poiana G; Biagioni S; Augusti-Tocco G
    J Neurosci Res; 2003 Dec; 74(5):760-8. PubMed ID: 14635227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R; Rubin JS; Funasaka Y; Cobb M; Boulton T; Faletto D; Rosen E; Chan A; Yoko K; White W
    Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
    Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
    Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
    Papassava P; Gorgoulis VG; Papaevangeliou D; Vlahopoulos S; van Dam H; Zoumpourlis V
    Cancer Res; 2004 Dec; 64(23):8573-84. PubMed ID: 15574764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A; Götze T; Korc M
    Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle cell activation by low-energy laser irradiation: a role for the MAPK/ERK pathway.
    Shefer G; Oron U; Irintchev A; Wernig A; Halevy O
    J Cell Physiol; 2001 Apr; 187(1):73-80. PubMed ID: 11241351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
    Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
    Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis.
    Day RM; Cioce V; Breckenridge D; Castagnino P; Bottaro DP
    Oncogene; 1999 Jun; 18(22):3399-406. PubMed ID: 10362361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoosmotic stress activates p38, ERK 1 and 2, and SAPK/JNK in rat hepatocytes.
    Kim RD; Darling CE; Cerwenka H; Chari RS
    J Surg Res; 2000 May; 90(1):58-66. PubMed ID: 10781376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2.
    Westermarck J; Li S; Jaakkola P; Kallunki T; Grénman R; Kähäri VM
    Cancer Res; 2000 Dec; 60(24):7156-62. PubMed ID: 11156425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.